Format

Send to

Choose Destination
Clin Vaccine Immunol. 2009 Apr;16(4):592-3. doi: 10.1128/CVI.00207-08. Epub 2009 Mar 11.

Evaluation of antibodies against different Epstein-Barr virus nuclear antigen 1 peptides in diagnosis of nasopharyngeal carcinoma.

Author information

1
State Key Laboratory of Oncology in Southern China, Guangzhou, China.

Abstract

Epstein-Barr virus nuclear antigen 1 (EBNA1) is a protein expressed consistently in nasopharyngeal carcinoma (NPC). Although antibody levels against three different EBNA1 peptides were all high in NPC patients, the correlation between any two biomarkers was low. Therefore, the selection of distinct EBNA1 peptides could render different results in serological detection for individuals with NPC.

PMID:
19279168
PMCID:
PMC2668280
DOI:
10.1128/CVI.00207-08
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for HighWire Icon for PubMed Central
Loading ...
Support Center